Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability.  Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.48
Ask: 15.58
Change: -0.26 (-1.65%)
Spread: 0.10 (0.646%)
Open: 15.68
High: 15.76
Low: 15.50
Prev. Close: 15.76
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

29 Apr 2024 07:00

RNS Number : 3062M
EnQuest PLC
29 April 2024
 

EnQuest PLC

29 April 2024

 

TRANSACTIONS IN OWN SHARES

 

EnQuest PLC (the "Company") announces that it will commence the share repurchase programme of its ordinary shares of 5 pence each (the "Ordinary Shares") of up to $15 million (the "Programme"), as first announced at its full year 2023 results on 28 March 2024.

The first phase of the Programme will be carried out through an agreement with Merrill Lynch International ("Merrill Lynch"), pursuant to which Merrill Lynch shall purchase Ordinary Shares as principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company. This agreement will initially run from 29 April 2024 to 30 June 2024 (subject to no regulatory objections or concerns arising), for an aggregate consideration of up to, but no greater than, $15 million. Merrill Lynch will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. While the Company has launched the Programme, there is no certainty on the volume of ordinary shares that may be purchased or any certainty on the pace and quantum of purchases.

Any purchase of Ordinary Shares under the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

The Company will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. It is intended that the first 25 million Ordinary Shares purchased under the Programme will be held in Treasury for issue in due course to the Company's Employee Benefit Trust to satisfy the anticipated future exercise of options and awards made to employees and Executive Directors of EnQuest PLC pursuant to certain of the Company's existing share plans. To the extent permitted by law, and after the initial 25 million Ordinary Shares are purchased, all additional Ordinary Shares purchased under the Programme will be cancelled.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Ends

 

For further information please contact:

 

EnQuest PLC

Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive Officer)

Jonathan Copus (Chief Financial Officer)

 

Chris Sawyer (General Counsel and Company Secretary)

 

Craig Baxter (Head of Investor Relations)

 

 

Teneo

Tel: +44 (0)20 7353 4200

Martin Robinson

 

Harry Cameron

 

 

Notes to editors

 

ENQUEST

 

EnQuest is providing creative solutions through the energy transition. As an independent energy company with operations in the UK North Sea and Malaysia, the Group's strategic vision is to be the partner of choice for the responsible management of existing energy assets, applying its core capabilities to create value through the transition.

 

EnQuest PLC trades on the London Stock Exchange.

 

Please visit our website www.enquest.com for more information on our global operations.

 

Forward-looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectations and plans, strategy, management's objectives, future performance, production, reserves, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this announcement should be construed as a profit forecast. Past share performance cannot be relied upon as a guide to future performance.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBDGDSXBDDGSI
Date   Source Headline
19th Mar 20204:16 pmRNSDirectorate Change
19th Mar 20207:00 amRNSOperations update
20th Feb 20203:58 pmRNSAdmission to Trading
4th Feb 20207:00 amRNSOperations update
31st Jan 202011:59 amRNSBond PIK Announcement
6th Jan 202012:14 pmRNSTotal Voting Rights
9th Dec 201910:39 amRNSDirector/PDMR Shareholding
4th Dec 201912:48 pmRNSBlock listing Interim Review
4th Dec 20197:00 amRNSEnQuest awarded Block PM409 PSC offshore Malaysia
3rd Dec 20192:32 pmRNSTotal Voting Rights
2nd Dec 20199:22 amRNSDirector/PDMR Shareholding
27th Nov 20198:40 amRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSOperations update
28th Oct 201910:33 amRNSDirector/PDMR Shareholding
21st Oct 201910:11 amRNSDirector/PDMR Shareholding
18th Oct 201910:25 amRNSTotal Voting Rights
11th Oct 201912:13 pmRNSDirector/PDMR Shareholding
9th Oct 20194:27 pmRNSDirector/PDMR Shareholding
2nd Oct 20191:08 pmRNSDirector/PDMR Shareholding
17th Sep 201911:25 amRNSHolding(s) in Company
16th Sep 201911:13 amRNSDirector/PDMR Shareholding
9th Sep 201911:44 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSChairman Succession
5th Sep 20197:00 amRNSResults for the six months ended 30 June 2019
2nd Sep 201912:04 pmRNSHolding(s) in Company
28th Aug 20193:22 pmRNSTotal Voting Rights
29th Jul 20199:27 amRNSTotal Voting Rights
17th Jul 201911:30 amRNSDirector/PDMR Shareholding
12th Jul 20193:00 pmRNSDirector/PDMR Shareholding
9th Jul 20199:15 amRNSDirector/PDMR Shareholding
1st Jul 20192:48 pmRNSDirector/PDMR Shareholding
27th Jun 20192:24 pmRNSReport on Payments to Govts
26th Jun 201911:54 amRNSTotal Voting Rights
25th Jun 20193:46 pmRNSDirector/PDMR Shareholding
18th Jun 201911:30 amRNSDirector/PDMR Shareholding
10th Jun 20192:33 pmRNSDirector/PDMR Shareholding
5th Jun 20194:12 pmRNSDirector/PDMR Shareholding
3rd Jun 201912:08 pmRNSDirector/PDMR Shareholding
30th May 20198:30 amRNSBlock Listing Application
28th May 20194:28 pmRNSDirector/PDMR Shareholding
23rd May 20194:54 pmRNSAGM Statement
23rd May 20197:00 amRNSOperations Update
20th May 20193:10 pmRNSDirector/PDMR Shareholding
13th May 20194:15 pmRNSDirector/PDMR Shareholding
8th May 201912:50 pmRNSDirector/PDMR Shareholding
26th Apr 20194:34 pmRNSDirector/PDMR Shareholding
17th Apr 20194:00 pmRNSNotice of AGM and Report & Accounts
8th Apr 201910:20 amRNSDirector/PDMR Shareholding
1st Apr 201911:36 amRNSDirector/PDMR Shareholding
27th Mar 20192:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.